Taysha Gene Therapies Inc (TSHA)
1.235
-0.10
(-7.84%)
USD |
NASDAQ |
Nov 05, 10:24
Taysha Gene Therapies Price: 1.235 for Nov. 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 1.57 | 1.57 | 1.335 | 1.34 | 7.218M |
| Nov 01, 2024 | 1.69 | 1.72 | 1.52 | 1.53 | 6.477M |
| Oct 31, 2024 | 1.85 | 1.87 | 1.68 | 1.69 | 2.095M |
| Oct 30, 2024 | 1.88 | 1.93 | 1.85 | 1.87 | 1.353M |
| Oct 29, 2024 | 2.00 | 2.00 | 1.88 | 1.88 | 1.869M |
| Oct 28, 2024 | 1.99 | 2.055 | 1.97 | 1.97 | 1.753M |
| Oct 25, 2024 | 1.97 | 2.05 | 1.97 | 1.99 | 1.455M |
| Oct 24, 2024 | 1.98 | 2.00 | 1.95 | 1.97 | 962118.0 |
| Oct 23, 2024 | 1.99 | 2.01 | 1.91 | 1.97 | 2.820M |
| Oct 22, 2024 | 2.01 | 2.02 | 1.90 | 1.99 | 2.118M |
| Oct 21, 2024 | 2.05 | 2.065 | 1.98 | 2.02 | 1.617M |
| Oct 18, 2024 | 2.04 | 2.06 | 2.02 | 2.06 | 744661.0 |
| Oct 17, 2024 | 2.04 | 2.06 | 2.005 | 2.03 | 1.097M |
| Oct 16, 2024 | 1.95 | 2.05 | 1.93 | 2.03 | 1.936M |
| Oct 15, 2024 | 1.99 | 1.99 | 1.92 | 1.95 | 955617.0 |
| Oct 14, 2024 | 2.00 | 2.01 | 1.97 | 1.99 | 936153.0 |
| Oct 11, 2024 | 1.98 | 2.05 | 1.96 | 2.01 | 1.985M |
| Oct 10, 2024 | 1.98 | 2.01 | 1.955 | 1.98 | 1.887M |
| Oct 09, 2024 | 2.00 | 2.029 | 1.96 | 2.00 | 1.356M |
| Oct 08, 2024 | 1.99 | 2.06 | 1.97 | 2.01 | 913155.0 |
| Oct 07, 2024 | 2.01 | 2.035 | 1.965 | 1.98 | 1.689M |
| Oct 04, 2024 | 2.05 | 2.09 | 2.01 | 2.01 | 1.413M |
| Oct 03, 2024 | 2.04 | 2.105 | 2.02 | 2.02 | 2.333M |
| Oct 02, 2024 | 2.00 | 2.09 | 1.99 | 2.05 | 1.557M |
| Oct 01, 2024 | 2.00 | 2.055 | 1.98 | 2.02 | 1.984M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.59
Minimum
Jun 28 2023
31.75
Maximum
Jan 20 2021
8.417
Average
3.07
Median
May 12 2022
Price Benchmarks
| CEL-SCI Corp | 0.8193 |
| AIM ImmunoTech Inc | 0.251 |
| IGC Pharma Inc | 0.375 |
| NovaBay Pharmaceuticals Inc | 0.76 |
| Protalix BioTherapeutics Inc | 1.28 |
Price Related Metrics
| PS Ratio | 18.63 |
| Price to Book Value | 2.325 |
| Earnings Yield | -70.01% |
| Market Cap | 253.10M |